Aflac Incorporated (AFL)

Aflac's stock price has been influenced by several events over the past six months. Aflac reported mixed results for the fourth quarter of 2025, with adjusted EPS missing analyst expectations but total revenue exceeding them, leading to a slight decrease in share price. For the first quarter of 2026, Aflac's adjusted EPS missed analyst estimates, but revenue exceeded forecasts, resulting in a stock decrease. Aflac Re Bermuda entered into a coinsurance agreement to reinsure a block of whole life annuities from Japan Post Insurance, which was described as immaterial to Aflac Inc.'s financials. In early April 2026, Evercore and Piper Sandler upgraded Aflac to "strong buy," while other firms maintained bearish outlooks and trimmed price targets after the Q1 earnings report. Japan Post Holdings Co., Ltd. reduced its stake in Aflac in April 2026, and other insider selling by executives has also been noted during this period.

There is evidence of demand seasonality for Aflac's products and services. Analysis of Aflac's seasonal charts suggests a historical "Buy Date of July 19 and a Sell Date of November 14" has resulted in outperformance compared to the S&P 500 Total Return Index over the past 20 years, indicating stronger performance between late summer and late autumn.

Aflac, Inc. is an American insurance company specializing in supplemental health and life insurance products, operating within the Financial sector. The company's business model focuses on providing financial protection through policies that offer cash benefits directly to policyholders for expenses not covered by primary health insurance. Aflac operates through two primary segments: Aflac Japan and Aflac U.S. Aflac Japan offers a comprehensive suite of insurance products and is a leader in cancer and medical insurance policies in Japan. Aflac U.S. provides a range of supplemental insurance products designed to provide supplemental coverage for individuals who already have major medical or primary insurance.

Aflac's primary geographic markets are the United States and Japan. The company's worldwide headquarters are located in Columbus, Georgia, U.S. Aflac also maintains other key offices in the U.S., including locations in Omaha, Nebraska; Columbia, South Carolina; Albany, New York; New York City, New York; Atlanta, Georgia; and Washington, D.C.

Aflac maintains a strong brand reputation, recognized for its iconic duck mascot and corporate philanthropy. Aflac has contributed over $100 million to childhood cancer research and treatment through a partnership with Children's Healthcare of Atlanta. The American Cancer Society named Aflac its 2025 Corporate Partner of the Year. No significant events negatively impacting Aflac's brand reputation in the past year were found in the search results.

Aflac's shareholder base is predominantly composed of institutional investors, who collectively hold a significant majority of its shares. Major institutional owners include Vanguard Group Inc., Japan Post Holdings Co., Ltd., BlackRock, Inc., and State Street Corp. Other notable institutional investors include Wells Fargo & Company/mn, Geode Capital Management, Llc, Morgan Stanley, and Northern Trust Corp. Insider ownership, representing executives and directors, accounts for a smaller percentage of the company's stock.